Patient-reported outcome measures in chronic kidney disease

• Research type

  Research Study

• Full title

  Using Patient-Reported Outcome measures (PROMs) to promote quality of care and safety in the management of patients with Advanced Chronic Kidney Disease. (PRO-trACK Project)

• IRAS ID

  200657

• Contact name

  Melanie Calvert

• Contact email

  m.calvert@bham.ac.uk

• Sponsor organisation

  University of Birmingham

• Clinicaltrials.gov Identifier

  RG_16-048, University of Birmingham Research Governance database

• Duration of Study in the UK

  1 years, 7 months, 30 days

• Research summary

  Background
  Chronic kidney disease (CKD) is associated with symptoms that can significantly reduce patients’ health-related quality of life (HRQOL). The symptoms/HRQOL of patients can be captured using self-reported questionnaires, known as patient-reported outcome measures (PROMs).

  Rationale
  Emerging evidence suggest that the use of electronic PROMs (ePROM) in routine clinical setting may improve outcomes at an individual patient level by enhancing the detection and monitoring of symptoms (Basch et al 2011). The use of ePROMs can also facilitate the tailoring of treatment to the individual needs of patients(Greenhalgh 2009, Hjollund 2014).
  The WestChronic System has been successfully implemented in Denmark for tailoring the care of various patient groups(Hjollund 2014). In the UK, the Advanced Symptom Management System (ASyMS)was successfully used to monitor the side effects of chemotherapy (McCann 2009).
  The aim of the PRO-trACK project is to explore the feasibility of using an ePROM system for symptom monitoring and individual management of adult patients with advanced CKD.

  Methods
  Following a systematic review and PPI facilitated PROM selection and topic guide development we will conduct:

  Study 1 - Usability testing
  Usability testing of the ePROM system with patients with CKD

  Study 2 – Qualitative Study
  (1) Qualitative interviews with patients with CKD and (2)focus groups/interviews with clinical staff from the UHB renal service, members of the myHealth team and hospital management or informatics team if required, to explore their views on the use and administration of the CKD ePROM system.

  Study 3 – ePROM Validation
  Assessment of the ePROM system with patients with CKD to establish reliability and validity.

• REC name

  West Midlands - Edgbaston Research Ethics Committee

• REC reference

  17/WM/0010

• Date of REC Opinion

  13 Feb 2017

• REC opinion

  Further Information Favourable Opinion